Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland - Takeaways - MDSpire

Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland

  • By

  • Natalia Anna Kaufmann

  • Peter Oppelt

  • Christoph Grimm

  • Julia Lastinger

  • Teresa Eichinger

  • Philip Trautner

  • Anja Hartl

  • Stefan Raidl

  • Dariga Ramazanova

  • Caroline Ines Preuss

  • April 20, 2026

Share

  • 1

    The survey reveals significant differences in the management of isolated STIC across German-speaking countries.

  • 2

    Current clinical guidelines for STIC show discrepancies, particularly regarding surgery, genetic testing, and follow-up care.

  • 3

    STIC lesions are associated with a high risk of developing peritoneal carcinomatosis, emphasizing their clinical importance.

  • 4

    The prevalence of isolated STIC is notably higher in BRCA-positive patients compared to those without BRCA mutations.

  • 5

    There is a pressing need for standardized clinical algorithms and consensus-based guidelines for managing isolated STIC.

Original Source(s)

Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland

  • by Natalia Anna Kaufmann, Peter Oppelt, Christoph Grimm, Julia Lastinger, Teresa Eichinger, Philip Trautner, Anja Hartl, Stefan Raidl, Dariga Ramazanova, Caroline Ines Preuss

  • April 20, 2026

Related Content

Immunotherapy does not impair ovarian function in a mouse model of breast cancer

Immune heterogeneity and therapeutic resistance in gynecological malignancies

Self-Sampling Shows Test Agreement

The study authors frame the device as a potential way to simplify screening, while emphasizing that larger validation studies are still needed.